Purchase Order 75D30126P20806
Award Date 2/25/26
Potential Completion Date 1/30/27
Potential Value $57K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not listed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Centers for Disease Control and Prevention awarded a $1,852.50 firm fixed price purchase order to Illumina, Inc. for an Illumina NextSeq Sequencer. As the sole manufacturer of this proprietary sequencing instrument, Illumina will deliver one NextSeq Sequencer to support genomic analysis activities at the CDC's Pittsburgh location. No set-aside provision was applied to this acquisition of an Illumina sequencing system, which will aid the CDC in disease detection, surveillance, and research...
- This federal contract award to Illumina, Inc. is for the purchase of a NEXTSEQ 1000 SEQ SYSTEM, a genetic sequencing instrument, by the Centers for Disease Control and Prevention (CDC) in Pittsburgh, PA. The $159,600.00 firm fixed-price purchase order does not have a set-aside designation. Illumina is a manufacturer and provider of genetic and genomic analysis instruments and reagents, and has received previous prime contract awards from federal agencies like the NIH, USDA, and VA to support...
- This is a firm fixed price Blanket Purchase Agreement (BPA) call order awarded to Illumina, Inc., a manufacturer of sequencing instruments and reagents, by the Centers for Disease Control and Prevention (CDC) Pittsburgh. The $67,395.38 award is for an "ILLUMINA PRODUCT CARE PLAN" to provide support and maintenance services for Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing platforms used by the CDC. This award is not associated with a set-aside program. Illumina has a...
- The Centers for Disease Control and Prevention (CDC) awarded a $245,344.27 firm-fixed-price purchase order to Illumina, Inc., a biotechnology company headquartered in San Diego, California. The contract is for annual maintenance services on Illumina's NextSeq1000 and MiSeq instruments over a 5-year period from September 9, 2024 through September 8, 2029. The services include health checks, preventive maintenance, and repairs as needed. This award was not set aside for any specific business...
- This is a firm-fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of sequencing and array-based solutions, for maintenance, repair, and support services on two Illumina NextSeq 1000 instruments. The $239,670.64 contract has a base period of 12 months and three 12-month option periods, with services to be performed in Atlanta, Georgia. The award was made under simplified acquisition procedures, and there were no set-aside...
- The Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $148,290.40 contract is for the provision of lab supplies, with a completion date of September 8, 2021. Illumina has a history of supporting federal agencies like the NIH, CDC, USDA, and VA with its sequencing instruments, reagents, and services....
- The Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh awarded a $19,502 purchase order to Illumina, Inc. for ISEQ 100NGS kits. The firm fixed price contract has a period of performance of one day, September 6, 2023. The place of performance will be Illumina's location in Atlanta, Georgia. The CDC is likely procuring the next generation sequencing kits to support genomic surveillance efforts within its broader infectious disease programs. No...
- This is a firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc. for a laboratory maintenance agreement covering the agency's Illumina MiSeq, MiSeqDX and NextSeq 550 next-generation sequencing systems. The $578,796.68 contract provides annual on-site preventative maintenance and 24-48 hour on-site repair services for the covered equipment, as Illumina is the original manufacturer and its factory-trained personnel have the required...
- This is a firm fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract, valued at $223,532.40, is for the maintenance and services of Illumina sequencing instruments. The contract has an ultimate completion date of April 4, 2025 and does not utilize any set-aside designations. Illumina, headquartered in San Diego, California, is a...
- This firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) in Pittsburgh to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $20,149 contract is for SUPPORT SERVICES - ISEQ MAINTENANCE, with a period of performance through June 14, 2026. Illumina is a veteran federal contractor, having provided sequencing systems, reagents, and services to support genomic research and diagnostics across...